Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine versus sufentanil in laparoscopic cholecystectomy
ChiCTR1900020716Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cholelithiasis, chronic cholecystitis and gallbladder polyp comparing Nalbuphine group with Sufentanil group (2 arms). Primary endpoint: Drug side effects. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
nalbuphinesufentanil
03
Conditions
cholelithiasischronic cholecystitisgallbladder polyp
Beyond the preview
Go deeper on ChiCTR1900020716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020716.